Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Sterling Pharma Solutions has commenced production of hydroxychloroquine (HCQ), a treatment currently under investigation for COVID-19.
read more
Tuesday, January 10, 2023
Sterling Pharma Solutions announced the completion of its acquisition of an active pharmaceutical ingredient (API) manufacturing facility in Ringaskiddy, Ireland, from Novartis, in a deal that was initially announced in March 2022.
read more
Wednesday, March 02, 2022
Sterling Pharma Solutions has reached an agreement with Novartis to acquire its Ringaskiddy campus (Novartis Ringaskiddy Limited), near Cork, Ireland. Financial details of the sale, which is expected to close in Q4, 2022, have not been disclosed.
read more
Tuesday, January 25, 2022
The project will include the construction of five new laboratories: two of which will be dedicated to research and development; a scale-up chemical synthesis laboratory; as well as Quality Control and analytical services laboratories. All work is due...
read more
Wednesday, January 24, 2018
API developer and manufacturer, Sterling Pharma Solutions, announced it is expanding its capacity in Japan.
read more
Sterling Pharma Solutions, is investing $1.5 million into a phased expansion of its US facility in North Carolina.
read more
Wednesday, April 24, 2019
Sterling Pharma Solutions, has received a Queen’s Award for International Trade for Outstanding Short Term Growth in overseas sales.
read more
Stevanato Group and CEPI have signed an agreement for the supply of 100 million Type 1 Borosilicate glass vials for a vaccine against COVID-19 virus, should product(s) be proven safe and effective.
read more
Stevanato Group announced the acquisition of a facility in Zhangjiagang for a new plant where the Company expects to begin renovations in the spring 2022, as part of the latest phase of its expansion in China.
read more
Capsugel recently published a study[1] in AAPS’ PharmSciTech journal confirming that Capsugel capsules are suitable excipients for Quality by Design (QbD)-based product development and manufacturing. The study examined the Critical Quality Attributes...
read more
Wednesday, February 11, 2015
Dishman Group has announced the successful completion of an inspection by the U.S. Food and Drug Administration (FDA) for its Netherlands site. The inspection, carried out by an USFDA investigator, was planned for 5 days but lasted 3 days, starting ...
read more
Wednesday, March 13, 2019
SGS welcomed the preliminary data from a controlled human infection trial with FluGen’s investigational M2SR vaccine.
read more
Wednesday, February 26, 2020
Sun Pharmaceutical has launched Riomet ER™ in the U.S. to improve glycemic control in patients 10 years of age and older with type 2 diabetes mellitus.
read more
Sun Pharma and Samsung BioLogics announced a strategic long-term manufacturing agreement for Tildrakizumab.
read more
Wednesday, December 30, 2020
SAI is voluntarily recalling Paroex Chlorhexidine Gluconate Oral Rinse USP, 0.12% products bearing an expiration date from 12/31/2020 – 9/30/2022 to the consumer level.
read more